Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet

Reuters2021-02-19

Feb 18 (Reuters) - The first dose of Pfizer Inc and BioNTech's COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet

medical journal has found.

The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine.

Overall infections, including among asymptomatic patients, were reduced by 75%.

Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants.

The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated.

(Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)

((Derek.francis@thomsonreuters.com))

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
1